[{"Assets_0_Q3_USD":7296954000.0,"CommonStockSharesOutstanding_0_Q3_shares":104219471.0,"EarningsPerShareBasic_1_Q3_USD":-1.7,"EarningsPerShareBasic_3_Q3_USD":-1.9,"EarningsPerShareDiluted_1_Q3_USD":-1.7,"EarningsPerShareDiluted_3_Q3_USD":-1.9,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":109746000.0,"NetIncomeLoss_1_Q3_USD":-147998000.0,"NetIncomeLoss_3_Q3_USD":-123422000.0,"StockholdersEquity_0_Q3_USD":3026309000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":87152000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":65097000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":87152000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":65097000.0,"Ticker":"SYNH","CIK":"1610950","name":"INC RESEARCH HOLDINGS, INC.","OfficialName":"Syneos Health Inc. Class A Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8107202548.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]